CARM logo

Carisma Therapeutics (CARM)

Profile

Full Name

Carisma Therapeutics, Inc.

Ticker Symbol

CARM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 6, 2014

Indexes

Not included

Website

http://www.carismatx.com

Employees

46

Key Details

Price

$0.20(+1.98%)

Market cap

Last Dividend

$0.36

TTM Dividend yield

-

Annual revenue

$19.63M(+31.59% YoY)

Annual EPS

-$1.46(+43.63% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.20
CARM price is $0.20

30-Day Relative Volume

0.21
CARM 30-day relative volume is 0.21

Price Performance

Price Most recent change

+1.98%
CARM price was up +1.98% on Apr 16, 2025

Price YTD change

-52.05%
CARM price is down -52.05% since January 1st

Price 1-year change

-88.18%
CARM price is down -88.18% year-on-year

Price 3-year change

-98.02%
CARM price is down -98.02% over the past 3 years

Price Range

Price All-time high

$386.66
CARM price is currently -99.95% below its historical high of $386.66

Price 3-year low

$0.16
CARM price is currently +25.56% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$8.40M
CARM market capitalization is $8.40 million

Market cap 3-year change

-
CARM market capitalization 3-year change is unknown

Market cap All-time high

$382.16M
CARM market capitalization is currently -97.80% below its historical high of $382.16 million

Market cap sector rank

18.26%
CARM market capitalization is higher than 18.26% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.59%
CARM shares outstanding is up +0.59% year-on-year

Shares Outstanding 3-Year Change

-
CARM shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.15
CARM beta is 1.15

200-day SMA

$0.76
CARM price is currently -73.41% below its 200-day simple moving average

50-day SMA

$0.37
CARM price is currently -45.94% below its 50-day simple moving average

RSI

29.30
CARM 14-day relative strength index is 29.30

Volume

0.21
CARM 30-day relative volume is 0.21

ATR

$0.04
CARM average true range is $0.04

10-day Historical Volatility

117.89%
CARM 10-day historical volatility is 117.89%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.36
CARM last dividend was $0.36 per share, with an ex-dividend date of March 8, 2023

Next Dividend

-
CARM next dividend has not yet been announced

Dividend per share

Dividend per share

-
CARM annual dividend per share value is unknown

Dividend per share Sector Rank

-
CARM annual dividend per share is unknown

Dividend per share 1-Year Change

-
CARM annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
CARM annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
CARM annual dividend yield value is unknown

Dividend yield Sector Rank

-
CARM annual dividend yield is unknown

Other

Payout ratio

-
CARM annual payout ratio value is unknown

Dividends paid

-
CARM annual dividends paid value is unknown

Free cash flow

-$60.04M
CARM annual free cash flow is -$60.04 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$19.63M
CARM annual revenue is $19.63 million

Revenue Analysts estimate

$16.91M
CARM annual revenue is currently +16.06% higher than the consensus analysts' forecast

Revenue 1-year change

+31.59%
CARM annual revenue is up +31.59% year-on-year

Revenue Sector rank

34.3%
CARM annual revenue is higher than 34.3% of companies in Healthcare sector

EPS

EPS

-$1.46
CARM annual earnings per share is -$1.46

EPS Analysts estimate

-$0.50
CARM annual earnings per share is currently +192.00% higher than the consensus analysts' forecast

EPS 1-year change

+43.63%
CARM annual earnings per share is up +43.63% year-on-year

EPS Sector rank

46.31%
CARM annual earnings per share is higher than 46.31% of companies in Healthcare sector

Profit

Gross profit

-
CARM annual gross profit value is unknown

Gross margin

-
CARM annual gross profit margin value is unknown

Operating profit

-$62.18M
CARM annual operating income is -$62.18 million

Operating margin

-316.72%
CARM annual operating profit margin is -316.72%

Net income

-$60.48M
CARM annual net profit is -$60.48 million

Net margin

-308.05%
CARM annual net profit margin is -308.05%

Expenses

Total expenses

$81.81M
CARM annual total expenses is $81.81 million

Operating expenses

$81.81M
CARM annual total operating expenses is $81.81 million

Cost of goods sold

-
CARM annual cost of goods sold value is unknown

Selling, general & administrative expenses

$22.14M
CARM annual SGA is $22.14 million

Depreciation and amortization

$3.35M
CARM annual depreciation & amortization is $3.35 million

Interest expense

-
CARM annual interest expense value is unknown

Income tax

-
CARM annual income tax value is unknown

EBIT & EBITDA

EBIT

-$62.18M
CARM annual earnings before interest & taxes is -$62.18 million

EBITDA

-$58.83M
CARM annual EBITDA is -$58.83 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$30.46M
CARM annual total assets is $30.46 million

Non current assets

$6.63M
CARM annual long term assets is $6.63 million

Current assets

$23.82M
CARM annual total current assets is $23.82 million

Cash and cash equivalents

$17.91M
CARM annual cash & cash equivalents is $17.91 million

Accounts receivable

-
CARM annual accounts receivable value is unknown

Inventory

-
CARM annual inventory value is unknown

Liabilities

Total liabilities

$58.37M
CARM annual total liabilities is $58.37 million

Long term liabilities

$42.31M
CARM annual total long term liabilities is $42.31 million

Current liabilities

$16.05M
CARM annual total current liabilities is $16.05 million

Accounts payable

$2.08M
CARM annual accounts payable is $2.08 million

Debt

Total debt

$2.48M
CARM annual total debt is $2.48 million

Total debt 1-year change

-20.56%
CARM annual total debt is down -20.56% year-on-year

Long term debt

$744.00K
CARM annual long term debt is $744.00 thousand

Short term debt

$1.74M
CARM annual short term debt is $1.74 million

Equity & Capital

Shareholders equity

-$27.91M
CARM annual stockholders equity is -$27.91 million

Book value

-$27.91M
CARM annual book value is -$27.91 million

Retained earnings

-$305.58M
CARM annual retained earnings is -$305.58 million

Working capital

$7.77M
CARM annual working capital is $7.77 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$59.92M
CARM annual cash flow from operations is -$59.92 million

Cash from operations 1-year change

+26.19%
CARM annual cash flow from operations is up +26.19% year-on-year

Cash from investing

-$123.00K
CARM annual cash flow from investing activities is -$123.00 thousand

Cash from investing 1-year change

-100.17%
CARM annual cash flow from investing activities is down -100.17% year-on-year

Cash from financing

$344.00K
CARM annual cash flow from financing activities is $344.00 thousand

Cash from financing 1-year change

-99.45%
CARM annual cash flow from financing activities is down -99.45% year-on-year

CAPEX

CAPEX

$123.00K
CARM annual capital expenditures is $123.00 thousand

CAPEX 1-year change

-89.13%
CARM annual capital expenditures is down -89.13% year-on-year

Free Cash Flow

Free cash flow

-$60.04M
CARM annual free cash flow is -$60.04 million

Free cash flow 1-year change

+27.06%
CARM annual free cash flow is up +27.06% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CARM annual gross profit margin value is unknown

Operating margin

-316.72%
CARM annual operating profit margin is -316.72%

Net margin

-308.05%
CARM annual net profit margin is -308.05%

ROA & ROE

ROA

-100.78%
CARM annual return on assets is -100.78%

ROE

216.69%
CARM annual return on equity is 216.69%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CARM price to earnings ratio value is unknown

PE ratio Sector rank

-
CARM price to earnings ratio is unknown

PB Ratio

PB ratio

-0.30
CARM price to book ratio is -0.30

PB ratio Sector rank

11.19%
CARM price to book ratio is higher than 11.19% of companies in Healthcare sector

PS Ratio

PS ratio

0.43
CARM price to sales ratio is 0.43

PS ratio Sector rank

15.51%
CARM price to sales ratio is higher than 15.51% of companies in Healthcare sector

Enterprise value

Enterprise value

-$7.03M
CARM enterprise value is -$7.03 million

Enterprise value Sector rank

5.87%
CARM enterprise value is higher than 5.87% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.12
CARM EV/EBITDA is 0.12

EV/EBITDA Sector rank

67.54%
CARM EV/EBITDA is higher than 67.54% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.48
CARM annual current ratio is 1.48

Quick ratio

-
CARM annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CARM annual debt to equity ratio is 0.00

Interest coverage ratio

-
CARM annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CARM piotroski f-score value is unknown

Altman Z-Score

-19.75
CARM altman z-score is -19.75

Analyst ratings

Recent major analysts updates

Apr 1, 25 D. Boral Capital
Buy
Jan 17, 25 D. Boral Capital
Buy
Jan 13, 25 D. Boral Capital
Buy
Dec 16, 24 HC Wainwright & Co.
Neutral
Dec 12, 24 D. Boral Capital
Buy
Dec 12, 24 Baird
Neutral
Dec 11, 24 Evercore ISI Group
In-Line
Dec 10, 24 BTIG
Neutral
Dec 9, 24 D. Boral Capital
Buy
Nov 25, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

APRE logo
Aprea Therapeutics (APRE)
AIMD logo
Ainos (AIMD)
BIAF logo
bioAffinity Technologies (BIAF)
POAI logo
Predictive Oncology (POAI)
DHAI logo
DIH Holdings US Class A (DHAI)
CTXR logo
Citius Pharmaceuticals (CTXR)
EVAX logo
Evaxion Biotech A/S (EVAX)
KPRX logo
Kiora Pharmaceuticals (KPRX)
Gelteq Limited (GELS)
  • What is the ticker symbol for Carisma Therapeutics?
  • Does Carisma Therapeutics pay dividends?
  • What sector is Carisma Therapeutics in?
  • What industry is Carisma Therapeutics in?
  • What country is Carisma Therapeutics based in?
  • When did Carisma Therapeutics go public?
  • Is Carisma Therapeutics in the S&P 500?
  • Is Carisma Therapeutics in the NASDAQ 100?
  • Is Carisma Therapeutics in the Dow Jones?
  • When was Carisma Therapeutics's last earnings report?
  • When does Carisma Therapeutics report earnings?
  • Should I buy Carisma Therapeutics stock now?

What is the ticker symbol for Carisma Therapeutics?

The ticker symbol for Carisma Therapeutics is NASDAQ:CARM

Does Carisma Therapeutics pay dividends?

No, Carisma Therapeutics does not pay dividends

What sector is Carisma Therapeutics in?

Carisma Therapeutics is in the Healthcare sector

What industry is Carisma Therapeutics in?

Carisma Therapeutics is in the Biotechnology industry

What country is Carisma Therapeutics based in?

Carisma Therapeutics is headquartered in United States

When did Carisma Therapeutics go public?

Carisma Therapeutics's initial public offering (IPO) was on February 6, 2014

Is Carisma Therapeutics in the S&P 500?

No, Carisma Therapeutics is not included in the S&P 500 index

Is Carisma Therapeutics in the NASDAQ 100?

No, Carisma Therapeutics is not included in the NASDAQ 100 index

Is Carisma Therapeutics in the Dow Jones?

No, Carisma Therapeutics is not included in the Dow Jones index

When was Carisma Therapeutics's last earnings report?

Carisma Therapeutics's most recent earnings report was on Nov 7, 2024

When does Carisma Therapeutics report earnings?

The next expected earnings date for Carisma Therapeutics is May 9, 2025

Should I buy Carisma Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page